Skip to main content

Qutenza News

High-Concentration Capsaicin Patch Can Cut Neuropathic Pain Intensity

WEDNESDAY, Feb. 7, 2024 – For patients with neuropathic pain, a high-concentration capsaicin patch (HCCP) is effective for reducing pain intensity, according to a study published online Feb. 7 in...

Averitas Pharma Announces FDA Approval of Qutenza for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy of the Feet

AACHEN, Germany and MORRISTOWN, N.J., July 21, 2020 /PRNewswire/ – Grünenthal announced today that its U.S. subsidiary Averitas Pharma, Inc. received U.S. Food and Drug Administration (FDA) approval ...

FDA Medwatch Alert: Over-The-Counter Topical Muscle and Joint Pain Relievers: Drug Safety Communication - Rare Cases of Serious Burns

ISSUE:  FDA is alerting the public that certain over-the-counter (OTC) products that are applied to the skin for the relief of mild muscle and joint pain have been reported to cause rare cases of ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Diabetic Neuropathy, Diabetic Nerve Damage, Persisting Pain, Shingles, Postherpetic Neuralgia, Neuropathic Pain, Peripheral Neuropathy, Pain

Qutenza patient information at Drugs.com